HeartSciences - 3 Year Stock Price History | HSCS
Historical daily share price chart and data for HeartSciences since 2022 adjusted for splits and dividends. The latest closing stock price for HeartSciences as of May 02, 2025 is 3.60.
- The all-time high HeartSciences stock closing price was 340.00 on February 03, 2023.
- The HeartSciences 52-week high stock price is 13.50, which is 275% above the current share price.
- The HeartSciences 52-week low stock price is 2.36, which is 34.4% below the current share price.
- The average HeartSciences stock price for the last 52 weeks is 3.90.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| HeartSciences Historical Annual Stock Price Data |
| Year |
Average Stock Price |
Year Open |
Year High |
Year Low |
Year Close |
Annual % Change |
| 2025 |
3.3025 |
3.7400 |
3.9900 |
2.7084 |
3.6000 |
-5.76% |
| 2024 |
6.9485 |
16.7200 |
17.9100 |
2.4800 |
3.8200 |
-77.66% |
| 2023 |
83.5080 |
83.3976 |
340.0000 |
14.9300 |
17.1000 |
-79.64% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MEDICAL INFO SYS |
$0.004B |
$0.000B |
|
Heart Test Laboratories, Inc. d/b/a HeartSciences is a medical technology company focused on applying innovative AI-based technology to an ECG (also known as an EKG) to expand and improve an ECG's clinical utility. Millions of ECGs are performed every week and the Company's objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. HeartSciences has one of the largest libraries of AI-ECG algorithms and is developing AI-ECG solutions to be made available on either a hardware agnostic cloud-based platform or its proprietary MyoVista? wavECG(TM) device, to help identify cardiovascular disease in any care setting worldwide in a manner to best suit different care providers. HeartSciences' first product candidate for FDA clearance, the MyoVista? wavECG(TM), or the MyoVista(R), is a resting 12-lead ECG that is also designed to provide diagnostic information related to cardiac dysfunction.
|
